The only free news source for serious moves across finance

Closer's Corner
Breaking news in finance without breaking open the wallet -- information democratized 💸Your source for the biggest moves in LBO, PE, M&A, and Wealth ManagementFollow us on Twitter for finance moves delivered straight to your home feed -- Enable notifications for real-time alerts straight to your home screenBreaking news in finance without breaking open the wallet -- information democratized 💸Your source for the biggest moves in LBO, PE, M&A, and Wealth ManagementFollow us on Twitter for finance moves delivered straight to your home feed -- Enable notifications for real-time alerts straight to your home screen

Archive

Browse all published articles from our finance deal feed

CAP

Banker Bonus Pools Rise 15% at Canada’s Big Lenders in Busy Year

Canada’s biggest lenders set aside 15% more for banker bonus pools in fiscal 2025, a year when the firms’ capital-markets divisions were more active on deals and US President Donald Trump’s policy swings kept trading desks busy.

Canada’s biggest lenders set aside 15% more for banker bonus pools in fiscal 2025, a year when the firms’ capital-markets divisions were more active on deals and US President Donald Trump’s policy swings kept trading desks busy.
Bloomberg Markets • Dec 4, 9:09 PM
REG

Compass Pathways Eyes FDA Approval for Psilocybin Depression Drug

Encouraging trial data is instilling both confidence and capital back into the psychedelic drug market, with estimates suggesting growth up towards $7 billion by the year 2032.

Encouraging trial data is instilling both confidence and capital back into the psychedelic drug market, with estimates suggesting growth up towards $7 billion by the year 2032. One pharmaceutical company, Compass Pathways, has begun final stage studies aimed at using psilocybin for the treatment of patients with depression. CEO Kabir Nath joined Carol Massar and Alexis Christoforous on 'Bloomberg Businessweek Daily' to discuss commercial viability for psilocybin and the future of the psychedelic drug development...
Bloomberg Politics • Dec 4, 9:04 PM
CAP

Young Koreans Dump Homeowner Dreams to Pile into Soaring Stocks

South Koreans are piling into equities at a record pace as they retreat from an overheating housing market — a shift that’s underscoring policymakers’ struggle to cool housing prices and ease discontent over affordability.

South Koreans are piling into equities at a record pace as they retreat from an overheating housing market — a shift that’s underscoring policymakers’ struggle to cool housing prices and ease discontent over affordability.
Bloomberg Markets • Dec 4, 9:00 PM
CAP

NYC Mayor Eric Adams Issues Order Banning Israel Divestment

New York City Mayor Eric Adams issued a pair of executive orders aimed at addressing antisemitism, his office said, weeks before Zohran Mamdani takes his place.

New York City Mayor Eric Adams issued a pair of executive orders aimed at addressing antisemitism, his office said, weeks before Zohran Mamdani takes his place.
Bloomberg Markets • Dec 4, 8:57 PM
REG

Trump’s DC Troop Deployment Allowed by Appeals Court for Now

A US appeals court will allow President Donald Trump to keep thousands of National Guard troops in Washington for now, temporarily halting a district judge’s ruling that declared the deployment unlawful.

A US appeals court will allow President Donald Trump to keep thousands of National Guard troops in Washington for now, temporarily halting a district judge’s ruling that declared the deployment unlawful.
Bloomberg Politics • Dec 4, 8:57 PM
REG

Trump Replaces Architect to Lead $300 Million Ballroom Design

President Donald Trump has tapped a new architect to help plan his $300 million White House ballroom wing, assigning the former lead designer to a consultant role in the high-profile and controversial project.

President Donald Trump has tapped a new architect to help plan his $300 million White House ballroom wing, assigning the former lead designer to a consultant role in the high-profile and controversial project.
Bloomberg Politics • Dec 4, 8:55 PM
REG

Stocks Waver as Traders Await Fed | Bloomberg Businessweek Daily 12/4/2025

On today's episode of Bloomberg Businessweek Daily, Carol Massar and Alexis Christoforous discuss today's market action as stocks waver near record highs and bonds decline ahead of next week's Fed decision.

On today's episode of Bloomberg Businessweek Daily, Carol Massar and Alexis Christoforous discuss today's market action as stocks waver near record highs and bonds decline ahead of next week's Fed decision. Bloomberg's Stuart Paul and Ira Jersey join the show to break it down. Plus, Compass Pathways CEO Kabir Nath talks possible FDA approval for the company's psilocybin depression drug and the path to commercial viability, and Weill Cornell Medicine Women's Heart Program Director Dr.
Bloomberg Politics • Dec 4, 8:46 PM
CAP

Your Medicare Advantage benefits are about to expire. How to get the most of the extras you’ve already paid for.

Use them or lose them: The Centers for Medicare and Medicaid Services just proposed vacating a rule that would have alerted beneficiaries about their unused benefits.

Use them or lose them: The Centers for Medicare and Medicaid Services just proposed vacating a rule that would have alerted beneficiaries about their unused benefits.
MarketWatch - Top Stories • Dec 4, 8:13 PM